Related Experiment Video
Updated: Apr 28, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Pristinamycin: old drug, new tricks?
Eden C Cooper1, Nigel Curtis2, Noel Cranswick2
1Department of Paediatrics, University of Melbourne, Victoria, Australia Infectious Diseases and Clinical Pharmacology Unit, Department of Medicine, The Royal Children's Hospital Melbourne, Victoria, Australia eden.cooper@rch.org.au.
Pristinamycin offers a safe, effective oral treatment for Gram-positive osteoarticular infections, including those caused by multidrug-resistant bacteria. This review examines its use for bone and prosthesis infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Orthopedics
Background:
- Osteoarticular infections caused by Gram-positive bacteria are a growing concern due to multidrug-resistant organisms.
- Current treatments often involve prolonged intravenous antibiotics, posing risks and logistical challenges.
- A safe and effective oral antibiotic option is highly desirable for these infections.
Purpose of the Study:
- To review the existing evidence on the efficacy of pristinamycin for treating osteoarticular infections.
- To evaluate pristinamycin's role in managing both native bone and prosthesis-related infections.
Main Methods:
- Systematic review of published literature.
- Analysis of studies reporting the use of pristinamycin for osteoarticular infections.
- Inclusion of data on Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.
Main Results:
- Pristinamycin demonstrates bactericidal activity against Gram-positive pathogens.
- The antibiotic has a history of use in Europe for over 50 years for osteoarticular infections.
- Evidence supports its use in both native bone and prosthesis-related infections.
Conclusions:
- Pristinamycin is a viable oral therapeutic option for Gram-positive osteoarticular infections.
- Its efficacy against multidrug-resistant strains like MRSA makes it valuable.
- Further research may solidify its role as a preferred oral treatment in this indication.
More Related Videos
11:56Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
08:13Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Mechanism of Antibiotic Resistance in MRSA
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...